首页 | 本学科首页   官方微博 | 高级检索  
检索        

大剂量程序化疗中与左旋门冬酰胺酶治疗相关的急性胰腺炎的观察
引用本文:王军陵,仲惟昆,陶卫平.大剂量程序化疗中与左旋门冬酰胺酶治疗相关的急性胰腺炎的观察[J].武汉大学学报(医学版),1999,20(2):1.
作者姓名:王军陵  仲惟昆  陶卫平
作者单位:Department of Pedliatrics,First Affiliated Hospital,Hubei Medical University,Wuhan 430060,China
摘    要:在大剂量程序化疗中使用左旋门冬酰胺酶(L Aspase) 共290 例次,并发急性胰腺炎(AP)1 例,观察表明使用L Aspase 引起的AP与药物的剂量、累积负荷量及疗程无明显相关关系,而与个体体质反应差异有关;大剂量程序化疗中L AsPase 使用具较高安全性;AP的早期诊断应警惕胰腺内分泌功能先行受损所致的糖尿病表现。

关 键 词:左旋门冬酰胺酶/副作用  急性胰腺炎  药物疗法

Observations of Acute Pancreatitis Induced by L Aspase in High Dose Programme Chemical Therapy
Wang Junling,Zhong Weikun,Tao Weiping,et al.Observations of Acute Pancreatitis Induced by L Aspase in High Dose Programme Chemical Therapy[J].Medical Journal of Wuhan University,1999,20(2):1.
Authors:Wang Junling  Zhong Weikun  Tao Weiping  
Abstract:times of chemical therapy with high dose L Asparaginase were observed in 1991.Only one case was complicated by acute pancreatitis (AP).The results show AP induced L Aspase has no obvious relation with the dose,cumulative load volume,and course of therapy,but has relation with difference of individual diathesis;L Aspase is quite safe in high dose chemical therapy;early diagnosis of AP should notice the manifestation of diabetes should be noticed before impairment of the endocrine function of pancreas.
Keywords:L  Aspase/AE  acute pancreatitis  drug therapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号